Das Borrelia burgdorferi Legionella IgG/IgM/IgA ELISA Kit (ABIN997005) ist ein Colorimetric ELISA Kit zur Detektion von Borrelia burgdorferi Legionella IgG/IgM/IgA.
Kurzübersicht für Legionella IgG/IgM/IgA ELISA Kit (ABIN997005)
Target
Legionella IgG/IgM/IgA
Reaktivität
Borrelia burgdorferi
Nachweismethode
Colorimetric
Methodentyp
Competition ELISA
Applikation
ELISA
Verwendungszweck
Legionella IgG/IgM/IgA ELISA Test System is an enzyme-linked immunosorbent assay for the qualitative detection of total antibody (IgG/IgM/IgA) to Legionella pneumophila serogroups 1-6 in human sera.
Analytische Methode
Qualitative
Spezifität
93.1%
Sensitivität
92.3%
Probenmenge
10 μL
Testdauer
1 - 2 h
Plattentyp
Pre-coated
Beschränkungen
Nur für Forschungszwecke einsetzbar
Lagerung
4 °C
Haltbarkeit
12-18 months
Target
Legionella IgG/IgM/IgA
Andere Bezeichnung
Legionella G/M/A
Substanzklasse
Antibody
Hintergrund
L. pneumophila was identified as the causative agent for Legionellosis (Legionella pneumonia, or Legionnaire's Disease) in 1977. Presently, there are more than 25 species and 33 serogroups in the family Legionellaceae, with at least 18 species associated with pneumonia, accounting for roughly 1-5% of all cases of pneumonia. L. pneumophila displays a multitude of morphologies including the bacillus, coccobacillus, and elongated fusiform. Although often difficult to perform, the Gram stain will be Gram-negative. The antibody response to L. pneumophila may be both specific and nonspecific, since the patient may have antibodies to similar antigens from other Gram-negative bacteria. Optimum times for specimen collection appear to be within the first week of illness, or as soon as possible after the onset (acute specimen), and at least 3 weeks after the onset (convalescent specimen). By the IFA method, a single result of 1:256 is considered presumptive evidence of legionella infection. Diagnostic titers have been reported to be absent in as many as 25% of patients, but the use of multiple Legionella species as the antigen source and a polyvalent conjugate directed against IgG, IgM, and IgA maximize the accuracy of serological procedures.